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Erikson’s Psychosocial Development
• Considering Erikson's psychosocial stage theory17, MDD 
w/ psychotic features onset seems to increase with ego 
development between adolescence & later life18.  
• When the fidelity of adolescence falls to the converse of 
identity, that is, identity confusion19, it throws a normative 
experience into a storm of insecurity, which easily can 
start and lead to a core disturbance.
• Young adulthood then begins as a search for intimacy, as 
those at this stage begin to turn outward in an attempt to 
share their newfound identity.  The antithesis of isolation 
enters, as those who failed to reconcile the preceding 
identity conflict feel either that they are psychologically 
misshapen or have no identity at all; ergo, when this 
person tries to share their sense of identity with a fully 
formed identity, often feel rejected and turn their anger, 
shame, and blaming behavior inward.
• Generativity vs stagnation is a stage where there is a 
final rejection of certain psychosocial values, which can 
lead to self-rejection when the identity is not functionally 
developed, intimacy was not properly shared, or with a 
conflict between self and one’s own held values.
Part 1: Background
Intro and Occurrence Stats
In recent years, Major Depressive Disorder (MDD) is 
becoming more normalized considering medication for it 
appears in commercials and other media on a regular basis.   
Psychotic symptoms, an often-misunderstood specifier for 
this disorder, are occurring more frequently while being 
discussed less often1.  However, MDD continues to affect:
• more than 8% of young adults 18 to 22 
• just under 7% of the United States general population 
• 20% of those affected eventually develop psychotic 
symptoms
According to the DSM 5, a psychotic disorder/symptom is a 
thought disorder in which a person will experience “gross 
deficits in reality testing”, usually involving hallucinations, 
delusions, disorganized speech, and perhaps 
disorganized/catatonic movements2.  While at first it seems 
that there is a clear division between MDD and such deficits, 
research shows psychotic comorbidity is not only revealed to 
be quite common, but also shown to be a significantly 
pertinent factor to the causes of MDD3. This confirms that 
“psychopathology is represented by a network of overlapping 
and reciprocally impacting dimensional liabilities”.  
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Current Research/Methods of Treatment
How can MDD develop psychotic features?  Some answers 
have be found in genetics4, neurochemicals5, and childhood 
trauma6.
Psychosis-specific treatment, 
such as Cognitive Behavioral 
Therapy (CBT), are now 
emerging as extremely 
effective in treating MDD7.  
There is a gap in the literature.  
Psycho-social developmental 
aspects need to be researched 
more thoroughly as they relate 
to the onset and development 
of MDD.
Genetics
Family members of those with major depressive 
disorder have a risk 2-4 times greater than the 
general population; heritability is approximately 
40%; and personality trait neuroticism accounts 
for a large part of this particular genetic liability13
. However, a list of innumerous limitations for 
choosing and testing candidate genes is headed 
by the fact that a single candidate gene has yet 
to reach genome-wide significance14.
Childhood Trauma and Psychosis 
One study utilized a strict definition of bullying encompassing a myriad of 
actions connected by an intention to overtly cause harm and found this 
type of bullying to be associated with reported psychotic symptoms, 
especially early in life15.  Further research acknowledges that “real 
world” bullying is not limited to a strict definition and still found bullying, 
under a broader definition, and other types of childhood adversity to be 
strongly associated with an increased risk for developing psychosis of 
some kind16
References
Neurochemistry
• The Dopamine Hypothesis states that 
symptoms of psychosis (particularly as 
seen in schizophrenia, which MDD with
psychotic features can mimic or even 
develop into) can be attributed to a 
disturbed dopaminergic signal transduction8
• Bupropion, better known as Wellbutrin, is 
currently one of the more prescribed anti-depressants, and according to 
Moreira9 extremely effective in the regulation of clinical depression; 
specifically, as it inhibits the reuptake of dopamine through the dopamine 
and norepinephrine transporters10.  It must be noted that this is an 
unusual function for an anti-depressant, although in this case it allows it to 
work in tandem with anti-psychotics such as Aripiprazole11.
• Despite proven success with some of the above mentioned medicative
methods, the fact remains that many adults struggling with MDD are not, 
in fact, able to achieve full or sustainable remission with one or even 
multiple attempts to find a strictly pharmacological solution12  
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Psychotic symptoms, in relation to MDD, are becoming a 
more prevalent issue.  While research exploring Tx beyond 
strictly medical solutions20 lends hope to the mental health field, 
more research needs to occur.  Upon examination of the current 
exploration and implications of the literature review, aspects of 
psycho-social development stages should also be researched to 
determine what, if any, relationship they have to the 
development of psychotic features of MDD.  
This research would inform mental health professionals in 
making treatment decisions.  It may also increase the amount of 
psychoeducation available to those experiencing MDD and the 
development of psychosis.
